Noreen Henig
Director/Board Member at AVIDITY BIOSCIENCES, INC.
Net worth: 8 118 $ as of 2024-03-30
Profile
Noreen Roth Henig is an Independent Director at Avidity Biosciences, Inc. and Lazard Growth Acquisition Corp.
I, and an Independent Director at Lazard Healthcare Acquisition Corp.
I.
She previously worked as Senior Director-Global Respiratory at Gilead Sciences, Inc., Director-Adult Cystic Fibrosis Care Centers at Cystic Fibrosis Foundation, Chief Development Officer at ProQR Therapeutics NV, Chief Medical Officer at Kezar Life Sciences, Inc., and Chief Medical Officer at Breath Therapeutics GmbH.
She received her undergraduate degree from Yale University in 1987 and her doctorate from Albert Einstein College of Medicine, Inc. in 1991.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KEZAR LIFE SCIENCES INC
0.01% | 2023-07-23 | 9,000 ( 0.01% ) | 8 118 $ | 2024-03-30 |
AVIDITY BIOSCIENCES INC
-.--% | 2023-06-14 | 0 ( -.--% ) | - $ | 2024-03-30 |
Noreen Henig active positions
| Companies | Position | Start |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 2019-08-21 |
| LAZARD GROWTH ACQUISITION CORP. I | Director/Board Member | 2021-02-08 |
Lazard Healthcare Acquisition Corp. I
 Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Lazard Healthcare Acquisition Corp. I is a blank check company, which engages in mergers, share exchanges, asset acquisitions, share purchases, and reorganizations. The company was founded on February 25, 2021 and is headquartered in New York, NY. | Director/Board Member | - |
Former positions of Noreen Henig
| Companies | Position | End |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2023-10-05 |
Breath Therapeutics GmbH
 Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breath Therapeutics GmbH is a clinical stage biopharmaceutical company, which engages in the development of inhaled therapeutics for respiratory diseases. It offers drug device platform, which consists of liposomal drug-aerosol formulations and cutting-edge inhalation technology. The company was founded by Jens Stegemann, Gerhard Boerner, Oliver Denk, and Anne Burger in 2016 and is headquartered in Munchen, Germany. | Chief Tech/Sci/R&D Officer | 2020-02-29 |
| PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 2017-11-30 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2013-12-31 |
Cystic Fibrosis Foundation
 Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 2007-12-31 |
Training of Noreen Henig
| Yale University | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| PROQR THERAPEUTICS N.V. | Health Technology |
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Medical/Nursing ServicesHealth Services Cystic Fibrosis Foundation is a donor-supported non-profit organization which focuses in the search for a cure for cystic fibrosis. The foundation funds cystic fibrosis research. It also supports and accredits a national care center network recognized by the National Institutes f Health as a model of care for a chronic disease. The company was founded in 1955 and is headquartered in Bethesda, MD. | Health Services |
Breath Therapeutics GmbH
Breath Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Breath Therapeutics GmbH is a clinical stage biopharmaceutical company, which engages in the development of inhaled therapeutics for respiratory diseases. It offers drug device platform, which consists of liposomal drug-aerosol formulations and cutting-edge inhalation technology. The company was founded by Jens Stegemann, Gerhard Boerner, Oliver Denk, and Anne Burger in 2016 and is headquartered in Munchen, Germany. | Health Technology |
Lazard Growth Acquisition Corp. I
 Lazard Growth Acquisition Corp. I SemiconductorsElectronic Technology Lazard Growth Acquisition Corp. I operates as a blank check company with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. The company was founded on December 10, 2020 and is headquartered in New York, NY. | Electronic Technology |
Lazard Healthcare Acquisition Corp. I
Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Lazard Healthcare Acquisition Corp. I is a blank check company, which engages in mergers, share exchanges, asset acquisitions, share purchases, and reorganizations. The company was founded on February 25, 2021 and is headquartered in New York, NY. | Finance |
- Stock Market
- Insiders
- Noreen Henig
